Introduction
Penicillin has been the accepted treatment for syphilis since the early 1940s. The drug is efficacious, safe, and easy to administer. The dosage and route of administration in early syphilis are now well standardised and agreed on but this is not the case in neurosyphilis. Treatment failures have occurred after treatment of neurosyphilis with procaine and benzathine penicillin.1-6 The problem becomes much more complex in the patient who is allergic to penicillin. Tetracycline or erythromycin are the drugs recommended as alternatives to penicillin but, since neither drug jpasses the blood brain barrier well their effectiveness in neurosyphilis is uncertain. 7 Chloramphenicol achieves adequate concentrations in the cerebrospinal fluid (CSF) and has been used successfully in the treatment of syphilis, although recently it has fallen into disrepute.8-'2
We report a case of general paresis of the insane which was successfully treated with chloramphenicol. [15] [16] [17] This has led to the recommendation that neurosyphilis should be treated with intravenous penicillin in high doses that will achieve adequate spirocheticidal concentrations in the CSF. '5-'7 The penetration of drugs into the CSF depends on their small molecular size, little or loose binding by plasma proteins, their lipid solubility, the presence and strength of ionic charge, the concentration of the agent in the blood, and the presence of inflammation.
Tetracycline does not pass the blood brain barrier well, achievable concentrations being only 10% of those in the serum. 18 Chloramphenicol is unique in its ability to penetrate into the CSF, where the concentration in healthy subjects is 33-507o of that in the blood.'9 Chloramphenicol is lipid soluble and has low protein binding and a small molecular size. Because of the association of aplastic anaemia with chloramphenicol its use has been restricted, but this complication is rare and occurs in only about 1 in 25 000 people exposed. '9 Although the follow up of this case was not ideal, we consider that the treatment was successful and suggest that intravenous chloramphenicol may be a more appropriate agent than tetracycline in penicillin allergic patients with neurosyphilis and should be further evaluated.
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